TECH Bio-Techne Corp
$72.60▼ -0.12%
Healthcare
Other
After hours
$72.60▲ +0.00%
Oct 27, 4:00 PM ET
Volume 2.43M
Avg Volume (10D) 2.72M
Key Metrics & Fundamentals
Market Cap
$11.39B
P/E Ratio
62.6
Div Yield
0.44%
52W Range
43.20 - 72.75
% vs 50 MA
0.23%
% vs 200 MA
15.11%
RSI-14
55.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.78
Free Cash Flow
$86.94M
Gross Rev
$321.19M
Gross Profit
$211.39M
EBITDA
$96.94M
COGS
$109.80M
Operating Exp
$116.40M
Operating Income
$95.00M
EBIT
$95.00M
Pretax Income
$70.68M
Net Income
$54.62M
EPS (Diluted)
0.35
Price & Volume History
Loading chart…
Recent News
Argus Downgrades Bio-Techne to Sell From Buy
MT Newswires · Oct 27, 2026 5:34 AM ET

1 healthcare stock for long-term investors and 2 we ignore
StockStory · Oct 26, 2026 2:30 PM ET

What You Need to Know Ahead of Bio-Techne’s Earnings Release
Barchart · Oct 26, 2026 10:15 AM ET

1 Unpopular Stock That Should Get More Attention and 2 We Question
StockStory · Oct 9, 2026 10:43 AM ET

Bio-Techne opens GMP small molecule facility in Bristol, UK
Pharmaceutical Technology · Oct 9, 2026 7:02 AM ET

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development
PR Newswire · Oct 8, 2026 8:00 AM ET

INCY or TECH: Which Is the Better Value Stock Right Now?
Zacks · Sep 30, 2026 10:40 AM ET

2 Cash-Producing Stocks Worth Investigating and 1 We Brush Off
StockStory · Sep 28, 2026 9:42 AM ET

Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package
Insider Monkey · Sep 25, 2026 11:57 PM ET

Is Bio-Techne Stock Outperforming the Nasdaq?
Barchart · Sep 24, 2026 4:47 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TECH's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.